Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BridgeBio Pharma Inc (BBIO) vs GameStop Corp. (GME) Price & Performance

BridgeBio Pharma IncTrade
GameStop Corp.Trade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs GameStop Corp. — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B), while GameStop Corp. trades at $18.82 (market cap $8.60B). The key difference: BridgeBio Pharma Inc is the larger of the two by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, GameStop Corp. nearer its low. Which is the better fit depends on your goals.

BBIOGME
Market Cap
$16.61B$8.60B
Sector
HealthConsumer Cyclical
52-Week High
$90.17$27.69
52-Week Low
$47.29$18.79
Enterprise Value
$18.16B$4.57B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO

About GameStop Corp.

Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.

Read more on GME